These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3219274)

  • 1. Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.
    Rubens RD; Tinson CL; Coleman RE; Knight RK; Tong D; Winter PJ; North WR
    Br J Cancer; 1988 Nov; 58(5):626-30. PubMed ID: 3219274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer.
    Stewart JF; Rubens RD; King RJ; Minton MJ; Steiner R; Tong D; Winter PJ; Knight RK; Hayward JL
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1307-14. PubMed ID: 6891929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer.
    Wang DY; Rubens RD; Clark GM; Moore JW; Bulbrook RD
    Breast Cancer Res Treat; 1988 Apr; 11(1):67-70. PubMed ID: 3382764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
    Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD
    Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced breast cancer in Egyptian women: clinical features and response to endocrine therapy. The Anglo-Egyptian Health Agreement Collaborative Study.
    Richards MA; Coleman RE; Hamsa R; Khaled H; el Mawla MG; Kadry I; Hablas A; Ramadan M; Allen D; Wang DY
    Eur J Surg Oncol; 1992 Jun; 18(3):219-23. PubMed ID: 1607031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer.
    Fentiman IS; Howell A; Hamed H; Lee SM; Ranson M; Wall J; Chaudary MA; Ash CM; Gregory WM; Sellwood RA
    Br J Cancer; 1994 Oct; 70(4):729-31. PubMed ID: 7917929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of endocrine therapy do not predict response to chemotherapy in advanced breast cancer.
    Steiner R; Stewart JF; Rubens RD
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1559-63. PubMed ID: 6685641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meakin adjuvant regimen in premenopausal patients with breast cancer.
    Smith D; Dewar JA; Horobin JM; Scott JS; Preece PE
    Br J Surg; 1990 Nov; 77(11):1219-20. PubMed ID: 2123727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
    Pyrhönen S; Valavaara R; Modig H; Pawlicki M; Pienkowski T; Gundersen S; Bauer J; Westman G; Lundgren S; Blanco G; Mella O; Nilsson I; Hietanen T; Hindy I; Vuorinen J; Hajba A
    Br J Cancer; 1997; 76(2):270-7. PubMed ID: 9231932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial to investigate the usefulness of the addition of prednisolone to tamoxifen as adjuvants to mastectomy in primary breast cancer patients with a high risk of recurrence: a preliminary report.
    DiMartino L; Demontis B; Mitchell IP; Hayward SW; Deshpande N
    Anticancer Res; 1991; 11(2):869-72. PubMed ID: 2064345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian irridation and prednisone versus tamoxifen (Nolvadex) in advanced breast cancer].
    Gundersen S; Kvaløy S; Fosså SD; Høst H
    Tidsskr Nor Laegeforen; 1983 Sep; 103(27):1873-5. PubMed ID: 6359581
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast.
    Williams G; Howell A; Jones M
    Br J Cancer; 1988 Nov; 58(5):631-4. PubMed ID: 3219275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
    Byrne MJ; Gebski V; Forbes J; Tattersall MH; Simes RJ; Coates AS; Dewar J; Lunn M; Flower C; Gill PG; Stewart J
    J Clin Oncol; 1997 Sep; 15(9):3141-8. PubMed ID: 9294477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer.
    Chien AJ; Duralde E; Hwang R; Tsung K; Kao CN; Rugo HS; Melisko ME; Esserman LJ; Munster PN; Cedars M; Kerlikowske K; McCulloch CE; Rosen MP
    Breast Cancer Res Treat; 2015 Aug; 153(1):173-81. PubMed ID: 26208485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.
    Nourmoussavi M; Pansegrau G; Popesku J; Hammond GL; Kwon JS; Carey MS
    Cancer Treat Rev; 2017 Apr; 55():26-35. PubMed ID: 28288389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    Gnant M; Mlineritsch B; Schippinger W; Luschin-Ebengreuth G; Pöstlberger S; Menzel C; Jakesz R; Seifert M; Hubalek M; Bjelic-Radisic V; Samonigg H; Tausch C; Eidtmann H; Steger G; Kwasny W; Dubsky P; Fridrik M; Fitzal F; Stierer M; Rücklinger E; Greil R; ; Marth C
    N Engl J Med; 2009 Feb; 360(7):679-91. PubMed ID: 19213681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letrozole in advanced breast cancer: the PO25 trial.
    Mouridsen HT
    Breast Cancer Res Treat; 2007; 105 Suppl 1(Suppl 1):19-29. PubMed ID: 17333340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norethisterone acetate as secondary endocrine treatment in advanced breast cancer.
    da Luz RJ; Rubens RD
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1879-80. PubMed ID: 2632269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.